These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 470233)

  • 1. [Clinical observations on renal vein blood fibrin degradation products (FDP) in glomerulonephritis (author's transl)].
    Tomura S
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):233-44. PubMed ID: 470233
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in blood coagulation in glomerulonephritis].
    Robeva R; Belovezhdov N; Genova V
    Vutr Boles; 1982; 21(6):1-7. PubMed ID: 6219496
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrin and fibrinogen degradation products in renal diseases. I. FDP in blood and urine in various stages of clinical glomerulonephritis].
    Ratajczak T; Szewczyk Z; Melcer H
    Pol Arch Med Wewn; 1977 Nov; 58(5):481-92. PubMed ID: 600826
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombocyte function and fibrinogen degradation products in glomerulonephritis].
    Fazlyeva RM
    Klin Med (Mosk); 1978 Nov; 56(11):75-81. PubMed ID: 723202
    [No Abstract]   [Full Text] [Related]  

  • 10. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)].
    Suzuki S; Tahara C; Kazama M
    Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulation studies in patients with kidney diseases].
    Girndt J; Wendt C; Köstering H
    Med Welt; 1982 Jan; 33(4):121-2. PubMed ID: 7062838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alterations in coagulation and fibrinolytic system in abruptio placentae (author's transl)].
    Saito H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):529-37. PubMed ID: 7069257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
    Wilmes EH; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.